首页> 外文期刊>Addiction biology >DRD2 DRD2 promoter methylation and measures of alcohol reward: functional activation of reward circuits and clinical severity
【24h】

DRD2 DRD2 promoter methylation and measures of alcohol reward: functional activation of reward circuits and clinical severity

机译:DRD2 DRD2启动子甲基化和酒精奖励测量:奖励电路的功能激活和临床严重程度

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Studies have identified strong associations between D2 receptor binding potential and neural responses to rewarding stimuli and substance use. Thus, D2 receptor perturbations are central to theoretical models of the pathophysiology of substance dependence, and epigenetic changes may represent one of the fundamental molecular mechanisms impacting the effects of alcohol exposure on the brain. We hypothesized that epigenetic alterations in the promoter region of the dopamine D2 receptor ( DRD2 ) gene would be associated with cue‐elicited activation of neural reward regions, as well as severity of alcohol use behavior. The current study leveraged functional neuroimaging (fMRI) during an alcohol reward paradigm ( n ?=?383) to test associations among DRD2 promoter methylation in peripheral tissue, signal change in the striatum during the presentation of alcohol cues, and severity of alcohol use disorder (AUD). Controlling for age, DRD2 promoter methylation was positively associated with responses to alcohol cues in the right accumbens (partial r ?=?0.144, P ?=?0.005), left putamen (partial r ?=?0.133, P ?=?0.009), right putamen (partial r ?=?0.106, P ?=?0.039), left caudate (partial r ?=?0.117, P ?=?0.022), and right caudate (partial r ?=?0.133, P ?=?0.009), suggesting that DRD2 methylation was positively associated with robust activation in the striatum in response to reward cues. DRD2 methylation was also positively associated with clinical metrics of AUD severity. Specifically, controlling for age, DRD2 methylation was associated with Alcohol Use Disorders Identification Test total (partial r ?=?0.140, P ?=?0.002); Impaired Control Scale total (partial r ?=?0.097, P ?=?0.044) and Alcohol Dependence Scale total (partial r ?=?0.152, P ?=?0.001). Thus, DRD2 methylation may be a critical mechanism linking D2 receptors with functional striatal brain changes and clinical severity among alcohol users.
机译:摘要研究已经确定了D2受体结合潜力和神经反应之间的强烈关联,以奖励刺激和物质使用。因此,D2受体扰动是物质依赖性病理学的理论模型的核心,并且表观遗传变化可能代表影响酒精暴露对大脑的影响的基本分子机制之一。我们假设多巴胺D2受体(DRD2)基因的启动子区的表观遗传学改变与神经奖励区域的提示激活相关,以及酒精使用行为的严重程度。目前的研究在酒精奖励范式(n?= 383)期间利用功能性神经成像(FMRI),以测试外周组织中DRD2启动子甲基化的关联,在醇提示呈现纹状体中的信号变化,以及酒精使用障碍的严重程度(澳元)。控制年龄,DRD2启动子甲基化与对右侧宫内的醇提示的反应正相关(部分R?= 0.144,P?= 0.005),左腐烂(部分R?0.133,P?= 0.009) ,右腐烂(部分r?=?0.106,p?= 0.039),留下尾部(部分r?=?0.117,p?= 0.022),右尾状(部分r?=Δ0.133,p?=? 0.009),表明DRD2甲基化与纹状体中的鲁棒激活呈正相关,以响应奖励提示。 DRD2甲基化也与AUD严重程度的临床指标正相关。具体地,控制年龄,DRD2甲基化与酒精使用障碍鉴定试验总量有关(部分R?= 0.140,P?= 0.002);控制秤总共受损(部分R?= 0.097,p?= 0.044)和醇依赖量表总量(部分R?= 0.152,P?= 0.001)。因此,DRD2甲基化可以是将D2受体的关键机制与功能性纹状体脑变化和酒精用户之间的临床严重程度连接。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号